Cargando…

Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn’s disease

BACKGROUND: Patients with newly diagnosed Crohn’s disease (CD) are associated with impaired physical and psychological well-being. These psychological characteristics are dynamic with the course of disease and could be influenced by medical treatment. Infliximab is effective and widely used in moder...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Maochen, Zhang, Tianyu, Hong, Liwen, Zhang, Chen, Zhou, Jie, Fan, Rong, Wang, Lei, Wang, Zhengting, Xu, Bin, Zhong, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973631/ https://www.ncbi.nlm.nih.gov/pubmed/29872273 http://dx.doi.org/10.2147/PPA.S156883

Ejemplares similares

The Efficacy of Infliximab Monotherapy versus Infliximab-Azathioprine Sequential Treatment in Crohn's Disease: Experience from a Tertiary Medical Center in China
por: Zhang, Tianyu, et al.
Publicado: (2016)

Infliximab for Crohn’s Disease Patients with Perianal Fistulas: Better Image, Better Life
por: Hong, Liwen, et al.
Publicado: (2020)

Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn’s disease
por: Zhang, Maochen, et al.
Publicado: (2016)

Patients' Educational Program Could Improve Azathioprine Adherence in Crohn's Disease Maintenance Therapy
por: Wang, Lei, et al.
Publicado: (2020)

Comparison between Intestinal Behçet's Disease and Crohn's Disease in Characteristics of Symptom, Endoscopy, and Radiology
por: Zhang, Tianyu, et al.
Publicado: (2017)

Prevalence of Sarcopenia and Its Effect on Postoperative Complications in Patients with Crohn's Disease
por: Zhang, Chen, et al.
Publicado: (2021)

Applying Machine Learning Models to Predict Medication Nonadherence in Crohn’s Disease Maintenance Therapy
por: Wang, Lei, et al.
Publicado: (2020)

Dynamics of the Salivary Microbiome During Different Phases of Crohn's Disease
por: Zhang, Tianyu, et al.
Publicado: (2020)

Comparison of patients’ tolerance between computed tomography enterography and double-balloon enteroscopy
por: Zhang, Maochen, et al.
Publicado: (2017)

Prognostic Analysis of Duodenal Gastrointestinal Stromal Tumors
por: Hong, Liwen, et al.
Publicado: (2018)

Preoperative Prognostic Nutritional Index and Nomogram for Predicting the Risk of Postoperative Complications in Patients With Crohn's Disease
por: Zhang, Chen, et al.
Publicado: (2023)

Association between STAT3 gene Polymorphisms and Crohn’s disease susceptibility: a case–control study in a Chinese Han population
por: Wang, Zhengting, et al.
Publicado: (2014)

The Diagnostic Yields and Safety of Double-Balloon Enteroscopy in Obscure Gastrointestinal Bleeding and Incomplete Small Bowel Obstruction: Comparison between the Adults and Elderly
por: Wang, Lei, et al.
Publicado: (2020)

Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation
por: Cheng, Mengmeng, et al.
Publicado: (2016)

Correction: Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation
por: Cheng, Mengmeng, et al.
Publicado: (2018)

mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile
por: Hu, Shurong, et al.
Publicado: (2016)

Chromogranin A: A Valuable Serum Diagnostic Marker for Non-Insulinoma Neuroendocrine Tumors of the Pancreas in a Chinese Population
por: Hong, Liwen, et al.
Publicado: (2020)

TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway
por: Sun, Juntao, et al.
Publicado: (2019)

Correction to: TRIM29 facilitates the epithelial-tomesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway
por: Sun, Juntao, et al.
Publicado: (2021)

Retraction Note: TRIM29 facilitates the epithelial‑to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway
por: Sun, Juntao, et al.
Publicado: (2022)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Second-line sunitinib for Chinese patients with advanced gastrointestinal stromal tumor: 37.5 mg schedule outperformed 50 mg schedule in adherence and prognosis
por: Zhang, Chenli, et al.
Publicado: (2021)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Multi-alleles predict primary non-response to infliximab therapy in Crohn’s disease
por: Zhang, Cai-Bin, et al.
Publicado: (2020)

Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients
por: Zhang, Maochen, et al.
Publicado: (2020)

Henoch-Schönlein purpura associated with infliximab therapy for pediatric Crohn’s disease
por: Li, Xiaolu, et al.
Publicado: (2022)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial
por: Jongsma, Maria M E, et al.
Publicado: (2022)

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy
por: Cao, Wan-Ting, et al.
Publicado: (2022)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Metastatic Crohn’s disease despite infliximab therapy
por: Campos, Sara, et al.
Publicado: (2017)

Myelolipoma After Infliximab Treatment for Crohn's Disease
por: Cesa, Kevin, et al.
Publicado: (2022)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn's Disease
por: Luo, Youyou, et al.
Publicado: (2017)

Efficacy of infliximab treatment on the mucosal healing of different intestinal segments in patients with ileocolonic Crohn’s disease
por: Wu, Yaling, et al.
Publicado: (2020)

Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease
por: Wang, Yizhong, et al.
Publicado: (2021)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Improvement with Infliximab of a Disseminated Sarcoidosis in a Patient with Crohn's Disease
por: Chebib, Nader, et al.
Publicado: (2014)

Infliximab therapy in pediatric Crohn’s disease: a review
por: Parashette, Kalyan Ray, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h35vsc14c2fjullak2fb5qsr01